VitriVax
VitriVax is a formulation technology company that develops solutions to enhance the global distribution and effectiveness of human vaccines. The company's core technology, Atomic Layering Thermostable Antigen and Adjuvant platform, addresses two major logistical barriers in vaccination. This platform eliminates the need for a cold chain by making vaccines thermostable, allowing them to be stored and transported at ambient temperatures up to 70°C for months.
Domain
vitrivaxbio.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$17.3M
Founded
2016
Tech Stack (19 technologies)
Frequently Asked Questions
What technologies does VitriVax use?+
VitriVax uses 19 technologies including Contact Form 7, GoDaddy CoBlocks, reCAPTCHA.
What industry is VitriVax in?+
VitriVax operates in the Biotechnology industry.
Where is VitriVax based?+
VitriVax is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026